LPL Financial’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Buy
17,441
+511
+3% +$6.3K ﹤0.01% 5541
2026
Q1
$188K Buy
16,930
+11,125
+192% +$99.6K ﹤0.01% 5522
2025
Q4
$31K Buy
5,805
+500
+9% +$3.66K ﹤0.01% 5762
2025
Q3
$46.8K Buy
+5,305
New +$46.8K ﹤0.01% 5643
2023
Q4
Sell
-1,100
Closed -$16.2K 4844
2023
Q3
$16.2K Hold
1,100
﹤0.01% 4624
2023
Q2
$27.6K Buy
+1,100
New +$18.4K ﹤0.01% 4486

Other funds holding IMUX

LPL Financial's IMUX Position: Q2 2026 in Review

LPL Financial increased its Immunic (IMUX) stake by 3% in Q2 2026, buying an estimated $6.3K and bringing the position to 17,441 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #5541.

LPL Financial first reported a position in IMUX in Q2 2023 and has held it in 6 quarters since. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • LPL Financial held 17,441 shares of Immunic worth $268K as of Q2 2026.
  • LPL Financial bought 511 Immunic shares in Q2 2026, an estimated $6.3K.
  • Immunic made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5541 holding.
  • LPL Financial first reported a position in Immunic in Q2 2023 and has held it in 6 quarters since.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.